Fineline Cube

Follow:
14735 Articles
CompanyDrug

Gilead’s Magrolimab Phase III Trial for AML Faces Partial Hold by FDA

Company

Ascentage Pharma’s 2023 Interim Report: 49% YOY Revenue Growth and Market Expansion

CompanyDrug

Pfizer’s RSV Vaccine Abrysvo Receives FDA Authorization for Maternal Immunization

CompanyDrug

J&J’s Teclistamab Granted Priority Review in China for Relapsed Multiple Myeloma

Company

Ascletis Pharma Inc. Reports 21.7% Revenue Increase in H1 2023, Led by Ritonavir Sales

Company

New Horizon Health Ltd Reports 264.6% YOY Revenue Increase and First Recurring Profits

CompanyDrug

Amgen’s Lumakras Faces Full Registration Review by FDA for KRAS-Mutated NSCLC

CompanyDrug

AstraZeneca’s Forxiga Demonstrates Clinical Benefits in Heart Failure and COPD Patients

Policy / Regulatory

NHSA Releases Preliminary Review Results for National Reimbursement Drug List Adjustments

Company

Novartis Sets Tentative Date for Sandoz Spin-Off, Targets October 4

Company

Jiangsu Hengrui Pharmaceuticals Reports 9.19% YOY Revenue Growth in H1 2023 Financial Report

Drug

AstraZeneca’s Forxiga Gains New Indication Approval in China for Chronic Heart Failure